The Indian Express

2 days ago | indianexpress.com | Debraj Deb

Tribal Affairs Minister Bikash Debbarma and BJP state president and Rajya Sabha MP Rajib Bhattacharjee also condemned Barman’s remark, made in Ambassa on Tuesday. While Debbarma warned that the Congress leader should face legal action if he did not apologise, Bhattacharjee said the remark reflected the Opposition party’s mindset on tribals. “Tribals in Tripura never got respect and dignity before the BJP came to power.

2 days ago | indianexpress.com | Bashaarat Masood

The four crucial infra projects in Jammu and Kashmir While the Centre has sanctioned a total of 19 projects, including tunnels, roadways, flyovers/elevated corridors and bridges, four of them are high-value projects with strategic importance. These are: a tunnel at Pir ki Gali on the Srinagar-Shopian-Bafliaz-Jammu road; the Sadhna tunnel on the Kupwara-Karnah road; a 28-km road stretch from Zaznar to Shopian in south Kashmir; and the resurfacing of the 68-km Trehgam-Chamkote road.

2 days ago | indianexpress.com | Nikhila Henry

Telangana Chief Minister A Revanth Reddy on Tuesday (June 24) challenged former state CM and Bharat Rashtra Samithi (BRS) leader K Chandrashekar Rao to a debate in the state Assembly over the contentious Banakacherla reservoir project. The BRS has been criticising the Congress government in the state for “allowing” the neighbouring Andhra Pradesh to go ahead with the project. Revanth Reddy said the debate would be about who actually compromised Telangana’s water interests.

2 days ago | indianexpress.com | Anonna Dutt

With the launch of Wegovy by Danish pharmaceutical giant Novo Nordisk and US major Eli Lilly’s Mounjaro already in circulation, Indians now have two injectable therapies for obesity management. Both therapies can be effective for weight loss, with users losing 15 per cent to 20 per cent of their body weight, almost equivalent to bariatric surgeries. This is significant considering obesity is on the rise in India, with nearly 254 million people living with it, according to the INDIAB study.

3 days ago | indianexpress.com | Anonna Dutt

AAs India’s astronaut Shubhanshu Shukla has blasted off into space on the Axiom-4 mission, he will be part of several medical experiments in space. These will not just be relevant to space travel but also to the future of therapy on Earth and precision medicine. The first is related to people with insulin-dependent diabetes and whether they can travel to space. As of now, they are not selected to become astronauts.